Nath Bio-Genes [NATHBIOGEN] vs UPL [UPLPP] Detailed Stock Comparison

Nath Bio-Genes (India) Limited

NSE
Loading...

UPL Ltd.

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Nath Bio-Genes (India) Limited wins in 12 metrics, UPL Ltd. wins in 8 metrics, with 0 ties. Nath Bio-Genes (India) Limited appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Nath Bio-Genes (India) Limited UPL Ltd. Better
P/E Ratio (TTM) 7.55 3.00 UPL Ltd.
Price-to-Book Ratio 0.50 1.63 Nath Bio-Genes (India) Limited
Debt-to-Equity Ratio 22.77 105.06 Nath Bio-Genes (India) Limited
PEG Ratio -0.20 -0.05 UPL Ltd.
EV/EBITDA 9.72 13.32 Nath Bio-Genes (India) Limited
Profit Margin (TTM) 9.68% 0.09% Nath Bio-Genes (India) Limited
Operating Margin (TTM) 3.94% 13.51% UPL Ltd.
EBITDA Margin (TTM) 3.94% 13.51% UPL Ltd.
Return on Equity 5.99% 2.01% Nath Bio-Genes (India) Limited
Return on Assets (TTM) 3.76% 0.86% Nath Bio-Genes (India) Limited
Free Cash Flow (TTM) $96.61M $84.56B UPL Ltd.
Dividend Yield 1.17% 0.69% Nath Bio-Genes (India) Limited
1-Year Return -16.73% 104.96% UPL Ltd.
Price-to-Sales Ratio (TTM) 0.73 1.38 Nath Bio-Genes (India) Limited
Enterprise Value $4.80B $724.61B UPL Ltd.
EV/Revenue Ratio 1.08 1.61 Nath Bio-Genes (India) Limited
Gross Profit Margin (TTM) 56.37% 54.76% Nath Bio-Genes (India) Limited
Revenue per Share (TTM) $234 $570 UPL Ltd.
Earnings per Share (Diluted) $22.69 $-0.74 Nath Bio-Genes (India) Limited
Beta (Stock Volatility) 0.57 0.83 Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited vs UPL Ltd. Stock Performance Analysis

Loading Price Chart...

NATHBIOGEN
UPLPP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Nath Bio-Genes (India) Limited1.56%1.72%5.03%19.82%10.69%8.15%
UPL Ltd.0.00%0.00%0.00%16.46%24.26%24.26%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Nath Bio-Genes (India) Limited-16.73%-13.64%-59.77%82.68%584.86%584.86%
UPL Ltd.104.96%104.96%104.96%104.96%104.96%104.96%

Performance & Financial Health Analysis: Nath Bio-Genes (India) Limited vs UPL Ltd.

MetricNATHBIOGENUPLPP
Market Information
Market Cap i₹3.27B₹620.31B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i53,1751,096
90 Day Avg. Volume i36,772441
Last Close₹169.02₹516.50
52 Week Range₹126.15 - ₹238.69₹216.20 - ₹563.85
% from 52W High-29.19%-8.40%
All-Time High₹585.00 (May 07, 2018)₹563.85 (Jul 30, 2025)
% from All-Time High-71.11%-8.40%
Growth Metrics
Quarterly Revenue Growth0.79%0.10%
Quarterly Earnings Growth-0.39%0.02%
Financial Health
Profit Margin (TTM) i0.10%0.00%
Operating Margin (TTM) i0.04%0.14%
Return on Equity (TTM) i0.06%0.02%
Debt to Equity (MRQ) i22.77105.06
Cash & Liquidity
Book Value per Share (MRQ)₹345.69₹318.92
Cash per Share (MRQ)₹0.39₹51.99
Operating Cash Flow (TTM) i₹-278,072,000₹70.93B
Levered Free Cash Flow (TTM) i₹386.00M₹7.59B
Dividends
Last 12-Month Dividend Yield i1.17%0.69%
Last 12-Month Dividend i₹2.00₹3.00

Valuation & Enterprise Metrics Analysis: Nath Bio-Genes (India) Limited vs UPL Ltd.

MetricNATHBIOGEN (Apr 24, 2026)UPLPP (Sep 14, 2025)
Price Ratios
P/E Ratio (TTM) i7.553.00
Forward P/E iN/AN/A
PEG Ratio i-0.20-0.05
Price to Sales (TTM) i0.731.38
Price to Book (MRQ) i0.501.63
Market Capitalization
Market Capitalization i₹3.27B₹620.31B
Enterprise Value i₹4.80B₹724.61B
Enterprise Value Metrics
Enterprise to Revenue i1.081.61
Enterprise to EBITDA i9.7213.32
Risk & Other Metrics
Beta i0.570.83
Book Value per Share (MRQ) i₹345.69₹318.92

Financial Statements Comparison: Nath Bio-Genes (India) Limited vs UPL Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNATHBIOGEN (2025)UPLPP (2025)
Revenue/Sales i3.65B462.62B
Cost of Goods Sold i1.25B245.26B
COGS % of Revenue i34.4%53.0%
Gross Profit i2.39B217.36B
Gross Margin i65.6%47.0%
Research & Development i124.17M1.08B
Operating Income (EBIT) i474.88M56.20B
Operating Margin i13.0%12.1%
EBITDA i587.86M74.08B
EBITDA Margin i16.1%16.0%
Pre-Tax Income i405.84M8.29B
Pre-Tax Income % of Revenue i11.1%1.8%
Income Tax i19.85M90.00M
Income Tax % of Revenue i0.5%0.0%
Net Income (Profit) i386.00M8.20B
Profit Margin i10.6%1.8%

Balance Sheet & Liquidity Metrics

MetricNATHBIOGEN (2025)UPLPP (2025)
Cash & Equivalents i885.28M94.78B
Total Current Assets i6.90B396.61B
Total Current Assets % of Revenue i189.1%85.7%
Total Current Liabilities i3.65B285.69B
Total Current Liabilities % of Revenue i100.1%61.8%
Long-Term Debt i129.76M192.56B
Long-Term Debt % of Revenue i3.6%41.6%
Total Shareholders Equity i6.44B378.26B
Retained Earnings i4.76B208.68B
Retained Earnings % of Revenue i130.5%45.1%
Property, Plant & Equipment i48.20M94.31B

Cash Flow Statement Comparison

MetricNATHBIOGEN (2025)UPLPP (2025)
Operating Cash Flow i-278.07M70.93B
Operating Cash Flow % of Revenue i-7.6%15.3%
Capital Expenditures i-78.15M-3.73B
Free Cash Flow i96.61M84.56B
FCF Margin i2.6%18.3%
Debt Repayment iN/A-21.37B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNATHBIOGENUPLPP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i19.00M844.43M
Float Shares i6.08M563.84M
% Held by Insiders i61.39%0.00%
% Held by Institutions i0.00%17.49%
% Held by Public i38.61%82.51%

Dividend Analysis & Yield Comparison: Nath Bio-Genes (India) Limited vs UPL Ltd.

MetricNATHBIOGENUPLPP
Last 12-Month Dividend i₹2.00₹3.00
Last 12-Month Dividend Yield i1.17%0.69%
3-Year Avg Annual Dividend i₹2.00₹1.00
3-Year Avg Dividend Yield i1.00%0.69%
3-Year Total Dividends i₹6.00₹3.00
Ex-Dividend DateAug 14, 2025Jul 11, 2025